Eric Karas Sells Shares of SPRY $SPRY
Key Points
- Eric Karas sold 25,000 shares of ARS Pharmaceuticals, Inc. ($SPRY).
- $SPRY last traded around $9.76.
Eric Karas, Chief Commercial Officer at ARS Pharmaceuticals, Inc. ($SPRY), sold 25,000 shares at an average price of $0.00. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
ARS Pharmaceuticals, Inc. ($SPRY) Stock
ARS Pharmaceuticals, Inc. Earnings
Analysts Set New Price Targets
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.